Talde and Espiga back medical equipment producer Deltalab

Financial details for the transaction were undisclosed. According to a statement, the company is keen on using the fresh capital to bolster its presence in the Spanish market, as well as to expand internationally across strategic markets. As part of the deal, Deltalab CEO José Sáez will maintain his position.

The deal marks the third transaction for Espiga's maiden vehicle, Espiga Equity Fund, which held a final close on €140m in October 2015.

Previous funding
In 2009, Talde acquired a 49.9% stake in the business via its Talde Capital II fund. As part of the deal, the company's CEO José Sáez retained a controlling stake.

Company
Founded in 1976 and headquartered in Barcelona, Deltalab produces and distributes instruments and reagents for laboratories, including pipes, filters, pipettes and basters.

The business claims to have a presence in 125 countries and posted a turnover of €33.2m in 2015.

People
Talde - José María Zalbidegoitia (chair).
Espiga Equity Partners - Carlos Prado (managing partner).
Deltalab - José Sáez (CEO).

Advisers
Equity - Montalban Atlas Capital (corporate finance); Grant Thornton (financial due diligence).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Healthcare
• Southern Europe
• Spain